{"url_path":"/sec/ngne/8-k/2026-07-02/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/1404644/0001404644-26-000050-index.html","accession_number":"0001404644-26-000050","cik":"0001404644","ticker":"NGNE","issuer_name":"Neurogene Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1404644/0001404644-26-000050-index.html","primary_entity_key":"0001404644","primary_entity_name":"Neurogene Inc."},"word_count":43,"has_tables":true,"body_markdown":"Item 8.01Other Events\n\nThe Company believes that the net proceeds from the Offering, together with its existing cash and cash equivalents, will be sufficient to enable the Company to fund its operating expenses and capital expenditure requirements into the first quarter of 2029."}